Compare, Analyse Panacea Biotech with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs ADCOCK INGRAM (S. Africa) - Comparison Results

PANACEA BIOTECH     Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PANACEA BIOTECH   ADCOCK INGRAM
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-19
ADCOCK INGRAM
Jun-14
PANACEA BIOTECH/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs354384-   
Low Rs138277-   
Sales per share (Unadj.) Rs74.6114.1-  
Earnings per share (Unadj.) Rs6.7-28.7-  
Cash flow per share (Unadj.) Rs15.5-23.8-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs57.289.5-  
Shares outstanding (eoy) m61.25168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.32.9 114.0%   
Avg P/E ratio x36.8-11.5 -320.6%  
P/CF ratio (eoy) x15.9-13.9 -114.5%  
Price / Book Value ratio x4.33.7 116.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m15,06155,714 27.0%   
No. of employees `0002.34.3 53.9%   
Total wages/salary Rs m1,4713,497 42.1%   
Avg. sales/employee Rs Th1,973.64,485.3 44.0%   
Avg. wages/employee Rs Th635.6814.5 78.0%   
Avg. net profit/employee Rs Th176.8-1,130.2 -15.6%   
INCOME DATA
Net Sales Rs m4,56719,256 23.7%  
Other income Rs m45135 33.2%   
Total revenues Rs m4,61219,390 23.8%   
Gross profit Rs m2,030-3,337 -60.8%  
Depreciation Rs m540831 65.0%   
Interest Rs m1,048522 201.0%   
Profit before tax Rs m486-4,555 -10.7%   
Minority Interest Rs m0-13 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m77285 27.1%   
Profit after tax Rs m409-4,852 -8.4%  
Gross profit margin %44.4-17.3 -256.5%  
Effective tax rate %15.9-6.2 -253.8%   
Net profit margin %9.0-25.2 -35.5%  
BALANCE SHEET DATA
Current assets Rs m2,41514,103 17.1%   
Current liabilities Rs m9,0777,935 114.4%   
Net working cap to sales %-145.932.0 -455.4%  
Current ratio x0.31.8 15.0%  
Inventory Days Days65111 58.7%  
Debtors Days Days71124 57.2%  
Net fixed assets Rs m8,3338,221 101.4%   
Share capital Rs m6189 68.6%   
"Free" reserves Rs m3,4430-   
Net worth Rs m3,50415,114 23.2%   
Long term debt Rs m4615,311 8.7%   
Total assets Rs m13,75528,551 48.2%  
Interest coverage x1.5-7.7 -18.9%   
Debt to equity ratio x0.10.4 37.5%  
Sales to assets ratio x0.30.7 49.2%   
Return on assets %10.6-15.2 -69.9%  
Return on equity %11.7-32.1 -36.4%  
Return on capital %38.7-19.8 -195.4%  
Exports to sales %20.90-   
Imports to sales %8.10-   
Net fx Rs m7360-   
CASH FLOW
From Operations Rs m1,0491,644 63.8%  
From Investments Rs m-54-505 10.6%  
From Financial Activity Rs m-1,0114,820 -21.0%  
Net Cashflow Rs m-205,959 -0.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.29 Rs / ZAR

Compare PANACEA BIOTECH With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare PANACEA BIOTECH With: FRESENIUS KABI ONCO.  DR. DATSONS LABS  TORRENT PHARMA  BIOCON   FULFORD INDIA  



Today's Market

Sensex, Nifty Recover From Day's Low to End Strong; JSW Steel and ICICI Bank Among Top Nifty Gainers(Closing)

Indian share markets recouped early losses during afternoon deals and ended today's volatile session higher.

Related Views On News

Most Popular

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

Top 3 Nifty ETFs to Buy Now (Fast Profits Daily)

Apr 20, 2021

In this video I tell you the three Nifty ETFs I think are the best.

A Stock with 700% Return Potential Comes with Additional Payoffs (Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

11x Bankruptcy to Bluechip Stock: A Rare India Revival Story (Profit Hunter)

Apr 16, 2021

There is no stopping this 11-bagger stock from significant upside.

Why Did the Market Crash on Monday? (Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

PANACEA BIOTECH SHARE PRICE


Apr 22, 2021 (Close)

TRACK PANACEA BIOTECH

  • Track your investment in PANACEA BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PANACEA BIOTECH

PANACEA BIOTECH 8-QTR ANALYSIS

COMPARE PANACEA BIOTECH WITH

FEATURED VIDEOS

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

The Dilemma of Investing in Bharti Airtel

More Featured Videos

MARKET STATS